Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Saleh Rakhshani"'
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The pharmaceutical industry is continually striving to innovate drug development and formulation processes. Orally disintegrating tablets (ODTs) have gained popularity due to their quick release and patient-friendly characteristic
Externí odkaz:
https://doaj.org/article/76ac5b399bea44eba8376797734b9567
Autor:
Mehri Momeni, Saleh Rakhshani, Mohammadreza Abbaspour, Faezeh Alizadeh, Nafiseh Sheikhi, Faezeh GhorbanZadeh, Zahra Habibi, Hamed Tabesh
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-5 (2023)
Abstract Objectives Tablet manufacturing development is costly, laborious, and time-consuming. Technologies related to artificial intelligence like ,predictive model ,can be used in the control process to facilitate and accelerate the tablet manufact
Externí odkaz:
https://doaj.org/article/9427969024764848af6e2a8a47e4b508
Publikováno v:
Nanomedicine Journal, Vol 9, Iss 1, Pp 77-86 (2022)
Purpose: Auraptene (AUR) is a monoterpene coumarin compound with several biological activities specifically anti-cancer. The bioavailability of AUR in biological fluids is negligible, thus, the cytotoxicity of this compound for the target cells is lo
Externí odkaz:
https://doaj.org/article/cc05def9b4c84a00ae626ee78e230e10
Autor:
Seyedeh Nesa Rezaeian Shiadeh, Farzin Hadizadeh, Elham Khodaverdi, Mahmoud Gorji Valokola, Saleh Rakhshani, Hossein Kamali, Ali Nokhodchi
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1229 (2023)
In the current research, novel drug delivery systems based on in situ forming gel (ISFG) (PLGA-PEG-PLGA) and in situ forming implant (ISFI) (PLGA) were developed for one-month risperidone delivery. In vitro release evaluation, pharmacokinetics, and h
Externí odkaz:
https://doaj.org/article/18eae61086c440488604864d0a2abdee
Autor:
Majid Zeinali, Amirhossein Sahebkar, Mohammad Reza Zirak, Sajed Rakhshani, Mahmoud Hashemzaei, Jamshid Tabeshpour, Saleh Rakhshani
Publikováno v:
Current pharmaceutical design. 24(26)
Prediction of pharmacokinetics and drug targeting is a challenge in drug design. There are different types of software that can help to predict the pharmacokinetic profile of a drug. Quantitative structure-activity relationship (QSAR) modeling is use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a95c7dda0c8a093f4724ce0047d25b7
https://pubmed.ncbi.nlm.nih.gov/30179125
https://pubmed.ncbi.nlm.nih.gov/30179125